ADHD 및 성인 ADHD에 대한 개념적 고찰 (2): ADHD의 정신병리와 진단 및 치료의 함의

키워드

참고문헌 (106)

1. Larsson H, "The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan", Psychol Med, 44, pp.2223~2229 (2014)
2. Nigg JT, "Temperament and developmental psychopathology", J Child Psychol Psychiatry, 47, pp.395~422 (2006)
3. James W, "The principles of psychology Vol 1" (1890), Henry Holt and Company
4. Anderson JR, "Cognitive psychology and its implications" (2004), Worth Publishers
5. Achenbach TM, "The classification of children’s psychiatric symptoms : a factor-analytic study", Psychol Monogr, 80, pp.1~37 (1966)
6. 4-18 and 1991 profile, "Manual for the child behavior checklist", pp.1991, Achenbach TM
7. Turygin NC, "The effect of DSM-5criteria on externalizing, internalizing, behavioral and adaptive symptoms in children diagnosed with autism", Dev Neurorehabil, 16, pp.277~282 (2013)
8. Regier DA, "The DSM-5 : Classification and criteria changes", World Psychiatry, 12, pp.92~98 (2013)
9. Loy JH, "Atypical antipsychotics for disruptive behaviour disorders in children and youths", Cochrane Database Syst Rev, (9), pp.CD008559~ (2012)[DOI]
10. 강웅구, "도파민 시스템과 항정신병 약물의 작용에 대한 이해", 신경정신의학, 50(4), pp.251~272 (2011), 대한신경정신의학회
11. Evenden J, "Impulsivity : a discussion of clinical and experimental findings", J Psychopharmacol, 13, pp.180~192 (1999)
12. Dalley JW, "Fractionating impulsivity : neuropsychiatric implications", Nat Rev Neurosci, 18, pp.158~171 (2017)
13. Dickman SJ, "Functional and dysfunctional impulsivity : personality and cognitive correlates", J Pers Soc Psychol, 58, pp.95~102 (1990)
14. Stevens A, "Evolutionary psychiatry: a new beninning" (2000), Routledge
15. 박창증, "진화정신의학 II-진화적 관점에서 본 정신기능 및정신질환", 신경정신의학, 57(2), pp.173~189 (2018), 대한신경정신의학회[DOI]
16. Videbeck SL, "Psychiatric mental health nursing" (2006), Lippincott Williams & Wilkins
17. Cannon WB, "Bodily changes in pain, hunger, fear, and rage: an account of recent researches into the function of emotional excitement" (1929), D. Appleton and Co
18. Axelson D, "Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study", J Clin Psychiatry, 73, pp.1342~1350 (2012)
19. Archibald SJ, "Utilization behavior : clinical manifestations and neurological mechanisms", Neuropsychol Rev, 11, pp.117~130 (2001)
20. Skirrow C, "Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder", J Affect Disord, 147, pp.80~86 (2013)
21. Barkley RA, "The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults", J Am Acad Child Adolesc Psychiatry, 49, pp.503~513 (2010)
22. Reimherr FW, "Emotional dysregulation in adult ADHD and response to atomoxetine", Biol Psychiatry, 58, pp.125~131 (2005)
23. Reimherr FW, "A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder", J Clin Psychiatry, 68, pp.93~101 (2007)
24. Hupfeld KE, "Correction to: Living “in the zone”: hyperfocus in adult ADHD", Atten Defic Hyperact Disord, 11, pp.209~ (2019)
25. Sedgwick JA, "The positive aspects of attention deficit hyperactivity disorder : a qualitative investigation of successful adults with ADHD", Atten Defic Hyperact Disord, 11, pp.241~253 (2019)
26. Smallwood J, "The restless mind", Psychol Bull, 132, pp.946~958 (2006)
27. Shepherd J, "Why does the mind wander", Neurosci Conscious, 2019, pp.niz014~ (2019)
28. Fabry RE, "Reconsidering the mind-wandering reader:predictive processing, probability designs, and enculturation", Font Psychol, 9, pp.2648~ (2019)
29. Feinstein A, "The pre-therapeutic classification of comorbidity in chronic disease", J Chron Dis, 23, pp.455~468 (1970)
30. Barkley RA, "Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment" (2014), The Guilford Press
31. Douglas VI, "Attention and the developments of cognitive skills", pp.173~248 (1979), Plenum Press
32. Bédard AC, "Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit", hyperactivity disorder, 2015, pp.56, 40~48
33. Coghill DR, "The neuropsychological effects of chronic methylphenidate on drug-naive boys with attentiondeficit", hyperactivity disorder, 2007, pp.62, 954~962
34. Brus MJ, "Adult ADHD vs. bipolar disorder in the DSM-5 era: a challenging differentiation for clinicians", J Psychiatr Pract, 20, pp.428~437 (2014)
35. Karaahmet E, "The comorbidity of adult attention-deficit", hyperactivity disorder in bipolar disorder patients, 2013, pp.54, 549~555
36. Pinna M, "Attention deficit-hyperactivity disorder in adult bipolar disorder patients", J Affect Disord, 243, pp.391~396 (2019)
37. Wingo AP, "A systematic review of rates and diagnostic validity of comorbid adult attention-deficit", hyperactivity disorder and bipolar disorder, 2007, pp.68, 1776~1784
38. Mucci F, "ADHD with comorbid bipolar disorders: a systematic review of neurobiological, clinical and pharmacological aspects across the lifespan", Curr Med Chem, 26, pp.6942~6969 (2019)
39. Perugi G, "The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder", Expert Opin Pharmacother, 16, pp.2193~2204 (2015)
40. Katzman MA, "Adult ADHD and comorbid disorders : clinical implications of a dimensional approach", BMC Psychiatry, 17, pp.302~ (2017)
41. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychiatric Association
42. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2000), American Psychiatric Association
43. Martinez-Raga J, "Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition", Int J Adolesc Med Health, 25, pp.231~243 (2013)
44. Olsen JL, "The effect of personality disorder symptoms on response to treatment with methylphenidate transdermal system in adults with attention-deficit", hyperactivity disorder, 2012, pp.14, ~
45. Boyd R, "What realism implies and what it does not", Dialectica, 43, pp.5~29 (1989)
46. Reale L, "Comorbidity prevalence and treatment outcome in children and adolescents with ADHD", Eur Child Adolesc Psychiatry, 26, pp.1443~1457 (2017)
47. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (1980), American Psychiatric Association
48. Biederman J, "Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study", Pediatrics, 124, pp.71~78 (2009)
49. Fredriksen M, "Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD : a review of controlled and naturalistic studies", Eur Neuropsychopharmacol, 23, pp.508~527 (2013)
50. Faraone SV, "Metaanalysis of the efficacy of methylphenidate for treating adult attention-deficit", hyperactivity disorder, 2004, pp.24, 24~29
51. Ramos-Quiroga JA, "Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines", Curr Med Res Opin, 29, pp.1093~1104 (2013)
52. Marchant BK, "Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale", Psychol Assess, 25, pp.942~950 (2013)
53. Conners CK, "Conners’ Adult ADHD Rating Scales (CAARS): technical manual" (1999), Multi-Health Systems, Inc
54. Rösler M, "Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD", World J Biol Psychiatry, 11, pp.709~718 (2010)
55. Young JL, "Once-daily treatment with atomoxetine in adults with attention-deficit", hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial, 2011, pp.34, 51~60
56. Adler LA, "Atomoxetine treatment in adults with attentiondeficit", hyperactivity disorder and comorbid social anxiety disorder, 2009, pp.26, 212~221
57. Biederman J, "longterm efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit", hyperactivity disorder, 2010, pp.30, 549~553
58. Levin FR, "Bupropion treatment for cocaine abuse and adult attention-deficit", hyperactivity disorder, 2002, pp.21, 1~16
59. Thapar A, "Attention deficit hyperactivity disorder", Lancet, 387, pp.1240~1250 (2016)
60. Asherson P, "Adult attentiondeficit hyperactivity disorder : key conceptual issues", Lancet Psychiatry, 3, pp.568~578 (2016)
61. Moffitt TE, "Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study", Am J Psychiatry, 172, pp.967~977 (2015)
62. Willcutt EG, "Validity of the executive function theory of attention-deficit", hyperactivity disorder : a meta-analytic review, 2005, pp.57, 1336~1346
63. Kofler MJ, "Reaction time variability in ADHD : a meta-analytic review of 319 studies", Clin Psychol Rev, 33, pp.795~811 (2013)
64. Cuthbert BN, "Toward the future of psychiatric diagnosis : the seven pillars of RDoC", BMC Med, 11, pp.126~ (2013)
65. Kozak MJ, "The NIMH Research Domain Criteria initiative:background, issues, and pragmatics", Psychophysiology, 53, pp.286~297 (2016)
66. Musser ED, "Attention-deficit", hyperactivity disorder:an integrated developmental psychopathology and Research Domain Criteria (RDoC) approach, 2019, pp.90, 65~72
67. Levy F, "Attentiondeficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study", J Am Acad Child Adolesc Psychiatry, 36, pp.737~744 (1997)
68. McLennan JD, "Understanding attention deficit hyperactivity disorder as a continuum", Can Fam Physician, 62, pp.979~982 (2016)
69. World Health Organization, "The ICD-10 classification of mental and behavioral disorders. Diagnostic criteria for research" (1993), World Health Organization
70. Verkuijl N, "Childhood attention-deficit", hyperactivity disorder, 2015, pp.350, h2168~
71. Weiss G, "Hyperactive children grown up : empirical findings and theoretical considerations" (1986), Guilford Press
72. Gittelman R, "Hyperactive boys almost grown up. I. Psychiatric status", Arch Gen Psychiatry, 42, pp.937~947 (1985)
73. Simon V, "Prevalence and correlates of adult attention-deficit hyperactivity disorder : metaanalysis", Br J Psychiatry, 194, pp.204~211 (2009)
74. Sibley MH, "Method of adult diagnosis influences estimated persistence of childhood ADHD : a systematic review of longitudinal studies", Lancet Psychiatry, 3, pp.1157~1165 (2016)
75. Conrad P, "From hyperactive children to ADHD adults : observations on the expansion of medical categories", Social Problems, 47, pp.559~582 (2000)
76. Caye A, "Life span studies of ADHD-conceptual challenges and predictors of persistence and outcome", Curr Psychiatry Rep, 18, pp.111~ (2016)
77. Cheung CH, "Childhood predictors of adolescent and young adult outcome in ADHD", J Psychiatr Res, 62, pp.92~100 (2015)
78. Young S, "A metaanalysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations", Psychol Med, 45, pp.247~258 (2015)
79. Zalsman G, "Adult ADHD : a new disease?", Int J Psychiatry Clin Pract, 20, pp.70~76 (2016)
80. Faraone SV, "Attention-deficit", hyperactivity disorder, 2015, pp.1, 15020~
81. Szasz T, "The origin of psychiatry : the alienist as nanny for troublesome adults", Hist Psychiatry, 6, pp.1~19 (1995)
82. Hacking I, "Causal cognition: a multidisciplinary debate", pp.351~394 (1995), Clarendon Press
83. Charland LC, "The Oxford handbook of philosophy and psychiatry", pp.159~175 (2013), Oxford University Press
84. Beauchaine TP, "Instantiating the multiple levels of analysis perspective in a program of study on externalizing behavior", Dev Psychopathol, 24, pp.1003~1018 (2012)
85. Sveanus F, "The Oxford handbook of philosophy and psychiatry", pp.1171~1184 (2013), Oxford University Press
86. Gordijin B, "Medical enhancement and posthumanity" (2008), Springer
87. Kramer PD, "Listening to Prozac" (1997), Penguin Books
88. Park CL, "Positive and negative consequences of alcohol consumption in college students", Addict Behav, 29, pp.311~321 (2004)
89. Kooij SJ, "European consensus statement on diagnosis and treatment of adult ADHD : The European Network Adult ADHD", BMC Psychiatry, 10, pp.67~ (2010)
90. Shellenberg TP, "An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations", Expert Rev Clin Pharmacol, 13, pp.825~833 (2020)
91. Clemow DB, "The potential for misuse and abuse of medications in ADHD : a review", Postgrad Med, 126, pp.64~81 (2014)
92. Collins R, "Interpretation of the evidence for the efficacy and safety of statin therapy", Lancet, 388, pp.2532~2561 (2016)
93. Collecton L, "The elusive line between enhancement and therapy and its effects on health care in the U.S", J Evol Technol, 18, pp.70~78 (2008)
94. Andén NE, "A quantitative study on the nigro-neostriatal dopamine neuron system in the rat", Acta Physiol Scand, 67, pp.306~312 (1966)
95. Berridge KC, "What is the role of dopamine in reward:hedonic impact, reward learning or incentive salience", Brain Res Brain Res Rev, 28, pp.309~369 (1998)
96. Watanabe M, "Increase of extracellular dopamine in primate prefrontal cortex during a working memory task", J Neurophysiol, 78, pp.2795~2798 (1997)
97. Murphy BL, "Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys", Proc Natl Acad Sci U S A, 93, pp.1325~1329 (1996)
98. Floresco SB, "Mesocortical dopamine modulation of executive functions: beyond working memory", Psychopharmacology(Berl), 188, pp.567~585 (2006)
99. Vijayraghavan S, "Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory", Nat Neurosci, 10, pp.376~384 (2007)
100. Howes OD, "The dopamine hypothesis of schizophrenia : version III--the final common pathway", Schizophr Bull, 35, pp.549~562 (2009)
101. Ujike H, "Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis", Ann N Y Acad Sci, 1025, pp.279~287 (2004)
102. Kraemer M, "Methylphenidate-induced psychosis in adult attention-deficit", hyperactivity disorder : report of 3 new cases and review of the literature, 2010, pp.33, 204~206
103. Hollis C, "Methylphenidate and the risk of psychosis in adolescents and young adults : a population-based cohort study", Lancet Psychiatry, 6, pp.651~658 (2019)
104. Vallersnes OM, "Psychosis associated with acute recreational drug toxicity : a European case series", BMC Psychiatry, 16, pp.293~ (2016)
105. Wilens TE, "Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature", J Am Acad Child Adolesc Psychiatry, 47, pp.21~31 (2008)
106. Colaneri N, "Physician practices to prevent ADHD stimulant diversion and misuse", J Subst Abuse Treat, 74, pp.26~34 (2017)

관련 논문AI추천